Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penny L Moore

Showing results (21-30 of 214) with videos related to

Pageof 22
Sort By:
Cell Host & Microbe|November 13, 2025
The Africa COVID-19 legacy-Improved vaccinology for pandemic preparednessPenny L Moore, Shabir A Madhi, Glenda Gray
Journal of Virology|May 5, 2022
Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb LineageDavid Sacks, Kevin Wiehe, Lynn Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogensJ Scott Shaffer, Penny L Moore, Mehran Kardar, et al.
Immunological Reviews|January 31, 2017
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodiesPenny L Moore, Jason Gorman, Nicole A Doria-Rose, et al.
Frontiers in Immunology|October 4, 2021
Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and BreadthRebecca T van Dorsten, Kshitij Wagh, Penny L Moore, et al.
The New England Journal of Medicine|June 1, 2022
Audio Interview: Dissecting the Host Response to SARS-CoV-2Eric J Rubin, Lindsey R Baden, Penny L Moore, et al.
Journal of Virology|July 20, 2007
N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralizationElin S Gray, Penny L Moore, Ralph A Pantophlet, et al.
Trends in Molecular Medicine|September 18, 2022
Antibody class-switching as a strategy to improve HIV-1 neutralizationCathrine Scheepers, Simone I Richardson, Thandeka Moyo-Gwete, et al.
Trends in Immunology|June 18, 2024
SARS-CoV-2 humoral immunity in people living with HIV-1Boitumelo M Motsoeneng, Jinal N Bhiman, Simone I Richardson, et al.
Journal of Virology|December 22, 2021
Single-Chain Variable Fragments of Broadly Neutralizing Antibodies Prevent HIV Cell-Cell TransmissionRebecca T van Dorsten, Lucia Reh, Alexandra Trkola, et al.
Pageof 22

Showing results (21-30 of 214) with videos related to

Sort By:
Pageof 22
Cell Host & Microbe|November 13, 2025
The Africa COVID-19 legacy-Improved vaccinology for pandemic preparednessPenny L Moore, Shabir A Madhi, Glenda Gray
Journal of Virology|May 5, 2022
Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb LineageDavid Sacks, Kevin Wiehe, Lynn Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogensJ Scott Shaffer, Penny L Moore, Mehran Kardar, et al.
Immunological Reviews|January 31, 2017
Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodiesPenny L Moore, Jason Gorman, Nicole A Doria-Rose, et al.
Frontiers in Immunology|October 4, 2021
Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and BreadthRebecca T van Dorsten, Kshitij Wagh, Penny L Moore, et al.
The New England Journal of Medicine|June 1, 2022
Audio Interview: Dissecting the Host Response to SARS-CoV-2Eric J Rubin, Lindsey R Baden, Penny L Moore, et al.
Journal of Virology|July 20, 2007
N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralizationElin S Gray, Penny L Moore, Ralph A Pantophlet, et al.
Trends in Molecular Medicine|September 18, 2022
Antibody class-switching as a strategy to improve HIV-1 neutralizationCathrine Scheepers, Simone I Richardson, Thandeka Moyo-Gwete, et al.
Trends in Immunology|June 18, 2024
SARS-CoV-2 humoral immunity in people living with HIV-1Boitumelo M Motsoeneng, Jinal N Bhiman, Simone I Richardson, et al.
Journal of Virology|December 22, 2021
Single-Chain Variable Fragments of Broadly Neutralizing Antibodies Prevent HIV Cell-Cell TransmissionRebecca T van Dorsten, Lucia Reh, Alexandra Trkola, et al.
Pageof 22